Get started

Stocktowatch

HDFCAMC- Technical and Fundamental ( Concall summary)NSE:HDFCAMC 📈 #HDFCAMC Performance Update 1/🧵 AUM Growth 🌟: A strong year for HDFC AMC with a 20% YoY increase in quarterly average AUM, hitting a record INR 47 trillion. Equity-oriented funds grew by 26% YoY, reaching INR 23.1 trillion. #AUMGrowth #EquityFunds 2/🧵 Debt Funds Surge 💰: The quarter saw debt funds' AUM rise to INR 10.3 trillion. The B30 MAAUM category also showed significant growth, indicating rising mutual fund acceptance in these markets. #DebtFunds #MarketExpansion 3/🧵 Record-Breaking AUM 🚀: For the first time, the company's quarterly average AUM crossed INR 5 trillion, reaching INR 5.25 trillion - a 22% YoY growth. #RecordGrowth #FinancialMilestones 4/🧵 Market Share Momentum 📈: HDFC AMC’s market share continues to rise, with an overall QAAUM market share of 11.2% and 12.5% excluding ETFs. #MarketShare #InvestmentGrowth 5/🧵 Equity-Oriented Focus 🌐: The company's asset mix is now more equity-oriented, making up 58% of the total AUM. Also, its unique investor base expanded to 7.9 million by September 2023. #EquityFocus #InvestorBase 🆕 New Product Launches 6/🧵 Diverse Offerings 🛍️: HDFC AMC launched various new funds, including non-cyclical consumer, transportation & logistics, technology, and pharma & healthcare funds. #FundLaunch #Diversification 💹 Financial Performance Insights 7/🧵 Revenue and Profit Surge 💸: The company’s revenue from operations for Q2 grew by 18% YoY to INR 6.43 billion, while operating profit increased by 20% YoY to INR 4.67 billion. #RevenueGrowth #ProfitIncrease 8/🧵 Cost Dynamics 💼: Staff costs rose by 11% YoY, and other expenses grew by 22% YoY. #OperationalCosts #FinancialHealth 🔄 Marketing and Distribution Strategies 9/🧵 Long-term Investing Focus 🔄: HDFC AMC emphasizes SIP and systematic transactions for disciplined, long-term investing. #SIP #LongTermInvestment 10/🧵 Strengthening Partnerships 🤝: The company is enhancing its collaboration with HDFC Bank to leverage the bank’s distribution network, adding a dedicated vertical for this channel. #StrategicPartnerships #BankingNetwork 11/🧵 Market Share Gains 📊: A combination of performance, product range, and distribution efforts has led to market share gains, particularly in SIP flows and unique investors. #MarketShare #InvestorGrowth 12/🧵 Customer-Centric Approach 🧑‍💼: The company's focus on individual customers has resulted in increased folios and average AUM per folio, with higher flow market share in HDFC Bank. #CustomerFocus #GrowthStrategy 🔍 Other Key Highlights 13/🧵 Dividends and Future Plans 💼: HDFC AMC expects an upward trend in dividend payout ratios and plans to launch new funds, subject to regulatory approvals. #Dividends #FuturePlans 14/🧵 Passive Investment Strategy 🛠️: The company is expanding its product offerings in the passive space while maintaining a balance with active investment strategies. #ETFs #InvestmentApproach 15/🧵 Cost and Guidance Outlook 🔭: Expectations are for employee costs to increase annually by high-single-digit or low-double-digit percentages. No specific guidance provided for the upcoming financial year. #CostOutlook #FutureGuidance 📈 Chart analysis 16/🧵Sharing my trances, and hopefully, the stock move towards the key levels with some strong financial performance in coming weeks and months 🔚 Stay tuned for more updates and insights on HDFC Asset Management and follow Peaceful Weekend Investing and your friend Shivendra Bhatia #HDFCAMC #InvestingJourney
NSE:HDFCAMCLong
by Peaceful-Weekend-Investing
NSE-TATACONSUM - Short term trend tracking up? NSE:TATACONSUM Tata Consumer Products Ltd, a prominent member of the Tata Group, is a key player in the food and beverage industry, both nationally and abroad. This tea company is the second largest in the world and dominates many markets. It has expanded beyond South Asia, with a particular focus on India. foothold in several other regions such as Canada, the United Kingdom, North America, Australia, Europe, the Middle East, and Africa. Acquisition of Food Business In FY2020, the company got the consumer products business from Tata Chemicals Ltd. This includes selling salt with the name 'Tata Salt', and food products like spices and pulses with the name 'Tata Sampann'. It was an all-equity deal. counts for about 71% of branded business revenues of the company. About 22% of the revenue comes from business operations outside of the local area, including Canada, the United States, the United Kingdom and Europe, the Middle East, and Australia. Branded Vs Non-Branded 90% of total revenues come from branded food & beverages business & the rest 10% comes from the non-branded business of company. Revenue segmentation India Beverages(37% of revenue) - Brands such as Tata Tea, Tata Gluco+, Himalayan, Tata Coffee Grand India Foods(27% of revenue) - Brands such as Tata Salt, Tata sampann, Tata Soulfull, Tata sampann yumside US Coffee(11% of revenue) - Brands such as Eight O'clock International Tea(15% of revenue) - Brands such as Tetley, teapigs, Good Earth Tata Coffee(10% of revenue) As of 9MFY23, Growth businesses include Tata Sampann, NourishCo, Tata Soulfull, and the RTE/RTC business (Tata Smartfooz) grew 53%YOY Tata Starbucks It is a joint venture between Tata Consumer Products and Starbucks Corporation of America wherein the company is working towards expanding the presence of Starbucks retail coffee stores in the subcontinent of India. Presently, it operates 311 Starbucks stores in the nation. source : screener disc: Invested first trance
NSE:TATACONSUMLong
by Peaceful-Weekend-Investing
3
JAT.N0000Falling Wedge Pattern. Wait for a break out in daily chart. Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
CSELK:JAT.N0000
by rukshan2102
NSE:CHENNPETRO - Can it break way multyear high this time?Chennai Petroleum Corporation Limited is in the business of refining crude oil to produce & supply various petroleum products and manufacture and sale of lubricating oil additives. Company has reduced debt. Stock is trading at 0.92 times its book value Company is expected to give good quarter Company has delivered good profit growth of 31.1% CAGR over last 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 54.7% Company's working capital requirements have reduced from 25.9 days to 11.0 days NSE:CHENNPETRO disc: No investment
NSE:CHENNPETRO
by Peaceful-Weekend-Investing
2
NSE:DBL Dilip Buildcon- Let's study what going on Dilip Buildcon (DBL): A Deeper Dive Into the Infrastructure Giant 🏗️ Once regarded as a wealth destroyer with a stark 61.19% decline in the past 5 years, Dilip Buildcon Limited (DBL) is now making headway in the Indian infrastructure sector. But, before diving into the details, let's shed some light on the company's background. 📖 Founded in 1987 by Mr. Dilip Suryavanshi, DBL has grown to be one of India's major construction and infrastructure development companies, headquartered in Bhopal, Madhya Pradesh. Despite its past performance, recent trends suggest DBL offers good value based on its Price-To-Sales Ratio (0.3x) compared to the industry average (2.2x). 💰 Reputed brokerage AnandRathi has assigned a 'Buy' call on DBL, with a one-year target price of Rs 255. That's quite a vote of confidence! 👍 In the recent Q4 FY23, two key highlights were the de-levering and steady pace of execution for Dilip's projects. The company managed to reduce its net debt in Q4 by approximately Rs 220 crore, bringing the net debt down to Rs 2,380 crore. This has led to an annual de-levering of Rs 360 crore for FY23. 💸 The firm's operating profitability may have been underwhelming, but the progressively dwindling margin-drain from the older order book and the rising contributions from recent orders show potential. The company is aiming for measured growth, keeping in mind that aggressive revenue growth could lead to increased working capital needs. 📊 Upcoming Projects and Initiatives 🚧 DBL is not just limiting its efforts to construction and infrastructure. The company has a clear focus on cash flow generation and continues to work on monetizing its assets. The implementation of LD slag has seen a GST reduction from 18% to 5%, benefitting the road construction, civil-related works, and cement sectors. This could mean a positive impact for companies like Ashoka Buildcon, IRB Infrastructure, Elgi Equipment, L&T, Ncc, NBCC, PNC Infratech, and of course, Dilip Buildcon. 👷‍♀️👷‍♂️ Wrapping Up 🔚 While DBL has faced some major setbacks, it is working diligently to turn things around. But as with any investment, always conduct thorough research and due diligence. DBL is an interesting company to keep an eye on, given its improving performance and recent initiatives. 👀 Disclaimer: Not invested The above information is for study purposes only and does not constitute investment advice.
NSE:DBL
by Peaceful-Weekend-Investing
(NSE:OCCL )Oriental Carbon on move up Market Share: # OCCL is the sole manufacturer of Insoluble Sulphur (IS) in the domestic market. Majority of demand for insoluble sulphur is derived from the automotive tyres industry. It enjoy a domestic market share of nearly 55%-60% and around 10% market share in the global market. OCCL has established itself as a preferred first/second supplier to all major tyre manufacturers in global markets Capacity as of FY20: # IS plant spread across 2 units (Dharuhera & SEZ Mundra) of 34,000 metric tonnes per annum. Upcoming Capex # Capacity expansion underway to expand the Insoluble Sulphur capacity by 11,000 MTPA & Sulphuric acid capacity by 42,000 MTPA, spread across two phases at its Dharuhera facility. Total project will cost 216 Cr, funded with a debt equity ratio of 2:1. Phase-I of IS capacity expansion by 5500 MTPA along with Sulphuric acid capacity at an outlay of 156 Cr is underway. Commissioning for the project has been pushed to July2021 from Q3FY21 as envisaged earlier for phase-1. reference: Screener.in
OLong
by Peaceful-Weekend-Investing
Hikal looking to call back glory day on chart.Hikal Ltd. is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. Presently, it is operating in the crop protection and pharmaceuticals space. Hikal Ltd CMP is 303.95. The Negative aspect of the company is High Valuation (P.E. = 45.8) and declining annual net profit. The company's Positive aspects are Low debt, zero promoter pledge, FIIs increasing stake, MFs increasing stake, and Improving cash from operations annually. Entry can be taken after closing above 311. Targets in the stock will be 320 and 329. The long-term target in the stock will be 350. Stop loss in the stock should be maintained at Closing below 292. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:HIKALLong
by Happy_Candles_Investment
Page Ind. is on the stage, which has been away from rage. Page Industries Ltd. is the exclusive licensee of JOCKEY International Inc. (USA) for the manufacture, distribution, and marketing of the JOCKEY brand in India, Sri Lanka, Bangladesh, Nepal, Oman, Qatar, Maldives, Bhutan, and the UAE. The Company is the exclusive licensee of Speedo International Ltd. for the manufacture, marketing, and distribution of the Speedo brand in India. Page Industries Ltd CMP is 37852.30. The Negative aspects of the company are High Valuation (P.E. = 82.7), Declining cash from operations annual, FIIs are decreasing stake, Promoter Holding decreasing. The positive aspects of the company are No debt, zero promoter pledge, MFs are increasing stake, Improving annual net profit. Entry can be taken after closing above 38159. Targets in the stock will be 38809 and 40834. The long-term target in the stock will be 42503 and 43581. Stop loss in the stock should be maintained at Closing below 35893. Page Industries is a portfolio stock and a long term investment idea. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:PAGEINDLong
by Happy_Candles_Investment
NSE : UJJIVANSFB - Train of this small finance bank left NSE:UJJIVANSFB Ujjivan Small Finance Bank Limited is a mass market focused bank in India, catering to financially unserved and underserved segments and committed to building financial inclusion in the country. It started its operations as Ujjivan Financial Services Limited, a Non-Banking Financial Company in 2005 with the mission to provide financial services to the ‘economically active poor’ who were not adequately served by financial institutions. disc: Invested , do you own research .
NSE:UJJIVANSFBLong
by Peaceful-Weekend-Investing
WAPO.N0000Closely monitor mentioned buy zone and strong support zone. Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
CSELK:WAPO.N0000Long
by rukshan2102
NSE:Lupin -trend change on card??? NSE:LUPIN Lupin Limited is an India-based pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the United States, India, South Africa, and across the Asia Pacific, Latin America, and others. It offers vitamins, minerals, supplements and neurological products. It has presence in the cardiovascular, dialectology, asthma, paediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments. Its complex generics portfolio includes Filgrastim, Peg-Filgrastim, Etanercept and Albuterol, and others. Its biosimilar products include Filgrastim, Peg-Filgrastim and Etanercept. Its specialty products consist of Solosec and NaMuscla. Its over-the-counter products include Softovac, Lupizyme, Aptivate, Lupisafe, Be One, V-Bath, and others. It supplies APIs for anti-retroviral, anti-malarial and others. Disc: Invested, please do you own research
NSE:LUPIN
by Peaceful-Weekend-Investing
V-Gaurd Industries taking a guard for Positive Break outV- guard industries based in Kochi; Kerala is a multi-product company catering to the mass consumption market. The Company is engaged in manufacturing, trading and selling of a wide range of Electronics, Electrical and Consumer Durables. Over the years V-Guard has sold into domestic, industrial and agricultural electronic goods and appliances category. V-Guard operates more than 10 plants across various geographies across India manufacturing multiple categories. V- guard industries Limited CMP is 299.90. The Negative aspects of the company are High Valuation (P.E. = 65), declining annual net profit, FIIs are decreasing stake and promoter Holding decreasing. The positive aspects of the company are Low debt, zero promoter pledge, MFs are increasing stake and improving cash from operations annual. Entry after closing above 304. Targets in the stock will be 312 and 324. Long term targets in the stock will be 335+. Stop loss in the stock should be maintained at closing below 281. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:VGUARDLong
by Happy_Candles_Investment
Trying to make a bottom Dr.Reddy's LabDr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products. Dr Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA).Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy Limited CMP is 5478. The Negative aspects of the company are FIIs are decreasing stake, MFs are decreasing stake and Promoter Holding decreasing. The positive aspects of the company are No debt, zero promoter pledge, improving annual net profit and improving cash from operations. Entry after closing above 5527. Targets in the stock will be 5642 and 5567. Long term targets in the stock will be 5847 and 5992. Stop loss in the stock should be maintained at closing below 5270. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:DRREDDYLong
by Happy_Candles_Investment